# Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty

> **NCT01452581** · NA · TERMINATED · sponsor: **Rigshospitalet, Denmark** · enrollment: 5 (actual)

## Conditions studied

- Arthroplasty, Hip

## Interventions

- **OTHER:** Red blood cell transfusion
- **DRUG:** Voluven

## Key facts

- **NCT ID:** NCT01452581
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452581, "Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01452581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*